Inventory of GenesFebruary 09, 2004Scientists at DKFZ screen fruit fly genome for cancer-relevant genes Dr. Michael Boutros of the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ) and an international team of collaborators have been the first to screen an almost complete genome for genes that could play a role in cancer. The results have been published in the latest issue of the journal Science. Most cancers are linked to changes in the genetic material. As a result, the affected cells multiply uninhibited or cannot be killed by the immune system. Now that the sequence of the human genome has been almost completely deciphered, the next key challenge is to uncover the role of each individual gene. Based on these findings cancer researchers are hoping to be able to develop new therapies. For their investigation, Boutros and his colleagues used blood cells of the fruit fly Drosophila, a model organism that particularly lends itself to genetic studies. Using advanced high-throughput techniques the researchers analyzed the function of almost 20,000 different genes. In the process, they identified more than 400 genes that are needed for cell proliferation and survival - key criteria for tumor development. Among those were numerous genes whose relatives in the human genome are involved in cancer. For example, mutations in the AML1 gene have been implicated in acute myeloid leukemia. While screening the Drosophila genome, the researchers discovered that the fruit fly counterpart of AML1 has a function in cell survival. Their findings support the hypothesis that a mutated AML1 gene prevents the cell from activating its natural program of self-destruction. Once cells start to multiply in an uncontrolled fashion, they become transformed into malignant tumor cells. Boutros, who heads the Boveri-Group "Signaling and Functional Genomics" at DKFZ, used a method called RNA interference, or RNAi, to selectively analyze the functions of individual genes. Scientists first selected from a database the sequence of information building blocks of all genes to be investigated. Based on this pattern artificial RNA copies are produced for each gene. The tailored RNA molecules are then applied to cells where they silence their natural gene counterparts. If, as a result, cells die or stop dividing, then the investigators know that the respective gene must play an important role in cell survival or proliferation. Since the method does not yet work genome-wide in human cells, researchers are using model organisms such as the fruit fly. The more insights scientists get into the molecular basis of cancer, the more apparent it becomes that it is rarely based on changes in a few individual genes. Rather, several small steps together cause the complex interactions of genes and gene products to fail, ultimately leading to the transformation of a cell. According to Boutros, the next logical step after deciphering the genome is a systematic investigation of gene functions. "The aim is to produce a kind of map," he explained. "Most of the 25,000 to 30,000 human genes are already marked on this map. As a next step, we have to decipher the street names, that means to understand the genes' tasks and interactions." Boutros and his group are also working on methods to use RNAi screening in human cells. This might allow, for example, to systematically determine the function of genes in tumor cells and compare them in different types of cancer. | |||||||||||||||||||||
|
Related Cancer Current Events and Cancer News Articles Metabolic reactions: Less is more in single-celled organisms A Northwestern University study has found a surprising similarity among four quite different organisms. The simplest organism, a bacterium called H. pylori, uses the same number of biochemical reactions (around 300) as yeast, the largest, most complex organism of the group, when optimizing growth. Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene. International study supports new standard of treatment for women with advanced ovarian cancer Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. Researchers Discover New Enzyme in Cancer Growth While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body. Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. Plants display 'molecular amnesia' Plant researchers from McGill University and the University of California, Berkeley, have announced a major breakthrough in a developmental process called epigenetics. They have demonstrated for the first time the reversal of what is called epigenetic silencing in plants. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||